CORRECTION article

Front. Immunol., 05 June 2023

Sec. Cancer Immunity and Immunotherapy

Volume 14 - 2023 | https://doi.org/10.3389/fimmu.2023.1229541

Corrigendum: Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy

  • 1. Department of Thyroid and Breast Surgery, Ningbo First Hospital, Ningbo, Zhejiang, China

  • 2. Department of Thyroid and Breast Surgery, Ningbo Hospital of Zhejiang University, Ningbo, Zhejiang, China

  • 3. Department of Geriatrics Medicine, The Affiliated Hospital of Medical School of Ningbo University, Ningbo, Zhejiang, China

  • 4. Reproductive Medicine Center, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China

  • 5. Key Laboratory of Reproductive Dysfunction Management of Zhejiang Province Assisted Reproduction Unit, Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

In the published article, there was an error in the author list, The incorrect author list appeared as “Kai Hong 1,2†, Kenan Cen 3†,Qiaoqiao Chen 4,5†, Ying Dai3†, Yifeng Mai3* and Yangyang Guo1,2* “. The corrected author list appears below:

Yangyang Guo 1,2†, Kenan Cen3†, Qiaoqiao Chen4,5†, Ying Dai3†, Yifeng Mai 3* and Kai Hong1,2*

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

thyroid cancer, cellular senescence, tumor microenvironment, signature, immunotherapy, prognosis

Citation

Guo Y, Cen K, Chen Q, Dai Y, Mai Y and Hong K (2023) Corrigendum: Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy. Front. Immunol. 14:1229541. doi: 10.3389/fimmu.2023.1229541

Received

26 May 2023

Accepted

30 May 2023

Published

05 June 2023

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

14 - 2023

Updates

Copyright

*Correspondence: Yifeng Mai, ; Kai Hong,

†These authors have contributed equally to this work

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics